Any significant lifestyle changes should be discussed with a healthcare professional to ensure they align with ongoing treatment
By normalizing hunger signaling and reducing compulsive eating urges, patients gain better control over eating behaviors previously experienced as involuntary
Mansur, S
When compared with the beneficial effects of these drugs on glucose metabolism, blood pressure, body weight and cardiovascular (and potentially even renal) endpoints, these agents have an overall beneficial risk/benefit-profile for treatment of patients with T2D
Retatrutide, identified by its developmental code LY-3437943, is an investigational medication created by Eli Lilly for treating obesity, overweight conditions, and associated metabolic disorders including type 2 diabetes
However, the glucagon receptor component is new regardless of your tirzepatide history, so starting above 2 mg is not recommended